Infant RSV Prevention Study (MELODY)
We are currently conducting a study to assess whether a new product, called Nirsevimab, protects infants against Respiratory Syncytial Virus (or RSV). This new product is similar to a product currently used, but requires only one dose to protect babies throughout the entire RSV season. Background on Respiratory Syncytial Virus (RSV) and Nirsevimab RSV is
Focus Area: Infectious Disease Prevention
Associated Location(s): Fort Defiance, AZGallup, NMNavajo NationShiprock, NM